Depressive symptoms and schizophrenia: A psychopharmacological approach

M. C. Mauri, S. Bravin, L. Fabiano, S. Vanni, L. Boscati, G. Invernizzi

Research output: Contribution to journalArticle

Abstract

The frequency of depression was assessed in 43 chronic schizophrenic patients during an acute exacerbation phase of schizophrenia. The dexamethasone suppression test was administered to all patients. Depressive symptomatology showed a prevalence from 16.3% for moderate symptoms to 23.2% for mild ones. Depressive symptoms occurred concurrently with the psychotic picture and resolved as the psychosis remitted. Depressive symptoms were not relative to age, sex, duration of illness, DST cortisol levels, drug dosages and extrapyramidal side effects while basal cortisol levels were negatively correlated with basal Hamilton score.

Original languageEnglish
Pages (from-to)555-558
Number of pages4
JournalEncephale
Volume21
Issue number5
Publication statusPublished - 1995

Keywords

  • depression
  • neuroleptic treatment
  • psychopharmacology
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Depressive symptoms and schizophrenia: A psychopharmacological approach'. Together they form a unique fingerprint.

  • Cite this

    Mauri, M. C., Bravin, S., Fabiano, L., Vanni, S., Boscati, L., & Invernizzi, G. (1995). Depressive symptoms and schizophrenia: A psychopharmacological approach. Encephale, 21(5), 555-558.